Home » Topics » Regulatory » Patents

Patents
RSS

H. Lundbeck describes PDE1 inhibitors

Nov. 16, 2016

ImmunoMet Therapeutics discloses OXPHOX inhibitors

Nov. 16, 2016

Arena Pharmaceuticals patents 5-HT2C receptor agonists

Nov. 16, 2016

Vallaurix presents MC1 receptor agonists

Nov. 15, 2016

Novartis develops FXR agonists

Nov. 15, 2016

Xiamen University describes ALK and/or c-Met inhibitors

Nov. 15, 2016

Katholieke Universiteit Leuven discloses PMDT nucleoside phosphonates

Nov. 15, 2016

Texas A&M University patents antimycobacterial agents

Nov. 15, 2016

Medshine Discovery presents JAK2 inhibitors

Nov. 14, 2016

The Vanderbilt University discloses M1 receptor PAMs

Nov. 14, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...